Diantha Duvall
CIK 1696784 · CFO · last filed 2026-07-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$18.8K
Companies
3
Total Filings
26
Lifetime Open-Market Net
-$55.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRIS | CFO | 3,885 | $4.83 | $18.8K | $0 | 7 | 2026-07-09 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | CHIEF FINANCIAL OFFICER | 75,388 | $0.00 | $45 | -$6.3K | 8 | 2022-06-03 |
| Bioverativ Inc. (BIVV) Delisted | Chief Accounting Officer | 0 | — | — | -$49.5K | 11 | 2018-03-08 |
Recent Filings · Page 2 of 3
26 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-17 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Mixed | +34,627 | -$3.2K | EDGAR |
| 2021-03-17 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Grant (A) | +37,500 | $0 | EDGAR |
| 2020-06-02 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Grant (A) | +6,623 | $0 | EDGAR |
| 2020-04-06 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Grant (A) | +12,299 | $0 | EDGAR |
| 2019-03-07 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-08 | Bioverativ Inc. (BIVV) Delisted | Disp (D) | −2,791 | $0 | EDGAR |
| 2018-03-05 | Bioverativ Inc. (BIVV) Delisted | Tax (F) | −105 | -$11.0K | EDGAR |
| 2018-02-26 | Bioverativ Inc. (BIVV) Delisted | Tax (F) | −168 | -$17.5K | EDGAR |
| 2018-02-15 | Bioverativ Inc. (BIVV) Delisted | Mixed | +936 | -$47.0K | EDGAR |
| 2018-02-02 | Bioverativ Inc. (BIVV) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.